NAIMMCQ Autoimmune Disorders Neurologic Infections Neuropathies A patient is receiving mitoxantrone (Novantrone) for treatment of secondary progressive multiple sclerosis (MS). This patient should be closely monitored for

A patient is receiving mitoxantrone (Novantrone) for treatment of secondary progressive multiple sclerosis (MS). This patient should be closely monitored for

Autoimmune Disorders Neurologic Infections Neuropathies

A patient is receiving mitoxantrone (Novantrone) for treatment of secondary progressive multiple sclerosis (MS). This patient should be closely monitored for

a) hypoxia.

b) renal insufficiency.

c) mood changes and fluid and electrolyte alterations.

d) leukopenia and cardiac toxicity.

Asnwer: leukopenia and cardiac toxicity.